These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

398 related articles for article (PubMed ID: 27338839)

  • 1. Long-Term Contrast Echocardiography and Clinical Follow-Up after Percutaneous Closure of Patent Foramen Ovale Using Two Different Atrial Septal Occluder Devices.
    Scalise F; Auguadro C; Sorropago G; Sorropago A; Novelli E; Finizio M; Specchia G
    J Interv Cardiol; 2016 Aug; 29(4):406-13. PubMed ID: 27338839
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mid-term results of interventional closure of patent foramen ovale with the Occlutech Figulla
    Neuser J; Akin M; Bavendiek U; Kempf T; Bauersachs J; Widder JD
    BMC Cardiovasc Disord; 2016 Nov; 16(1):217. PubMed ID: 27832757
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Amplatzer or Figulla Flex II Occluder: a comparative study of outcomes after transcatheter patent foramen ovale closure.
    Toggweiler S; Moccetti F; Conrad N; Loretz L; Madanchi M; Bossard M; Attiger-Toller A; Cuculi F; Wolfrum M
    J Invasive Cardiol; 2024 Apr; 36(4):. PubMed ID: 38412438
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Flatstent versus the conventional umbrella devices in the percutaneous closure of patent foramen ovale.
    Aral M; Mullen M
    Catheter Cardiovasc Interv; 2015 May; 85(6):1058-65. PubMed ID: 25413379
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-Term Outcomes and Complications of Intracardiac Echocardiography-Assisted Patent Foramen Ovale Closure in 1,000 Consecutive Patients.
    Rigatelli G; Pedon L; Zecchel R; Dell'Avvocata F; Carrozza A; Zennaro M; Mazza A; Zuin M; Russo M; Zanchetta M
    J Interv Cardiol; 2016 Oct; 29(5):530-538. PubMed ID: 27500752
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of Outcomes after Device Closure with Transseptal Puncture and Standard Technique in Patients with Patent Foramen Ovale and Ischemic Events.
    Moon J; Kang WC; Kim S; Kim MG; Oh PC; Park YM; Chung WJ; Choi DY; Lee JY; Lee YB; Hwang HY; Ahn T
    J Interv Cardiol; 2016 Aug; 29(4):400-5. PubMed ID: 27282763
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Propensity-Score Matched Comparison of the Cera PFO Occluder With the Amplatzer PFO Occluder for Percutaneous Closure of Patent Foramen Ovale Without Echocardiographic Guidance.
    Ulmi M; Praz F; Siontis GCM; Wahl A; Windecker S; Mattle HP; Meier B
    J Invasive Cardiol; 2017 Aug; 29(8):280-284. PubMed ID: 28570259
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Figulla PFO occluder versus Amplatzer PFO occluder for percutaneous closure of patent foramen ovale.
    Saguner AM; Wahl A; Praz F; de Marchi SF; Mattle HP; Cook S; Windecker S; Meier B
    Catheter Cardiovasc Interv; 2011 Apr; 77(5):709-14. PubMed ID: 20931665
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transcatheter interatrial septal defect closure in a large cohort: midterm follow-up results.
    Aytemir K; Oto A; Özkutlu S; Canpolat U; Kaya EB; Yorgun H; Şahiner L; Sunman H; Ateş AH; Kabakçı G
    Congenit Heart Dis; 2013; 8(5):418-27. PubMed ID: 23601507
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Medium-term results of transcatheter closure of patent foramen ovale (PFO) with Amplatzer PFO and Cribriform occluders.
    Białkowski J; Wawrzyńczyk M; Karwot B; Fiszer R; Knop M; Szkutnik M
    Kardiol Pol; 2012; 70(11):1142-6. PubMed ID: 23180522
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Patent foramen ovale with complex anatomy: Comparison of two different devices (Amplatzer Septal Occluder device and Amplatzer PFO Occluder device 30/35).
    Giordano M; Gaio G; Santoro G; Palladino MT; Sarubbi B; Golino P; Russo MG
    Int J Cardiol; 2019 Mar; 279():47-50. PubMed ID: 30344060
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Safety and efficacy of Cardi-O-fix occluder for percutaneous closure of a patent foramen ovale: A single-center prospective study.
    Zhao E; Liu W; Zhang Y; Cheng G; Du Y; He L; Wang X; He X
    Medicine (Baltimore); 2017 Apr; 96(14):e6572. PubMed ID: 28383438
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Percutaneous Closure of Patent Foramen Ovale in Patients With Migraine: The PREMIUM Trial.
    Tobis JM; Charles A; Silberstein SD; Sorensen S; Maini B; Horwitz PA; Gurley JC
    J Am Coll Cardiol; 2017 Dec; 70(22):2766-2774. PubMed ID: 29191325
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term follow-up outcomes in a real-world study cohort after percutaneous patent foramen ovale closure.
    Ateş AH; Yorgun H; Canpolat U; Şener YZ; Okşul M; Kaya EB; Şahiner ML; Topcuoğlu MA; Arsava EM; Aytemir K
    Turk Kardiyol Dern Ars; 2021 Jan; 49(1):29-39. PubMed ID: 33390571
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Comparison Between Gore Cardioform and Amplatzer Septal Occluder for Percutaneous Closure of Patent Foramen Ovale Associated With Atrial Septal Aneurysm: Clinical and Echocardiographic Outcomes.
    Musto C; Cifarelli A; Dipasquale F; Chin D; Nazzaro MS; Stio RE; Pennacchi M; De Felice F
    J Invasive Cardiol; 2021 Nov; 33(11):E857-E862. PubMed ID: 34653958
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transcatheter closure of patent foramen ovale (PFO) in patients with paradoxical embolism: procedural and follow-up results after implantation of the Amplatzer®-occluder device.
    Fischer D; Haentjes J; Klein G; Schieffer B; Drexler H; Meyer GP; Schaefer A
    J Interv Cardiol; 2011 Feb; 24(1):85-91. PubMed ID: 20735710
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transthoracic echocardiography guidance during percutaneous closure of patent foramen ovale.
    Oto A; Aytemir K; Ozkutlu S; Kaya EB; Yorgun H; Canpolat U; Ateş AH; Ozkutlu H
    Echocardiography; 2011 Nov; 28(10):1074-80. PubMed ID: 21967656
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Patent foramen ovale closure with the Occlutech Figulla flex II device: A long-term (up to 10-years) follow-up.
    Trabattoni D; Gili S; Calligaris G; Teruzzi G; Troiano S; Ravagnani P; Santagostino Baldi G; Montorsi P
    Int J Cardiol; 2023 Sep; 387():131116. PubMed ID: 37301447
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term results of a randomized trial comparing three different devices for percutaneous closure of a patent foramen ovale.
    Hornung M; Bertog SC; Franke J; Id D; Taaffe M; Wunderlich N; Vaskelyte L; Hofmann I; Sievert H
    Eur Heart J; 2013 Nov; 34(43):3362-9. PubMed ID: 23842846
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Percutaneous closure of inter-atrial communications (atrial septal defect and patent foramen ovale): single-centre experience and mid-term follow-up.
    Van de Bruaene A; Stroobants D; Benit E
    Acta Cardiol; 2015 Apr; 70(2):133-40. PubMed ID: 26148372
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.